Elravie Premier Ultra Volume-L (1 x 1.0 ml)Manufacturer for sale

Elravie Premier™ is a monophasic dermal filler containing 23 mg/mL of non-animal hyaluronic acid, developed using patented HI Crosslinking Technology. Clinically proven to reduce residual BDDE by 38% compared to conventional methods, it demonstrates 96.7% patient satisfaction in volumetric corrections. Provides 9-12 months duration with minimal edema risk (reported in only 2.3% of cases). Manufactured by Humedix Co., Ltd. (ISO 13485 certified).

• Advanced Safety: HI Technology reduces BDDE residues by 38%, achieving 0.12ppm (FDA limit: 2ppm)
• Longevity: 9-12 month duration with stable crosslinked HA matrix
• Versatility: Suitable for deep folds, facial contouring & injection rhinoplasty
• Low Reactivity: Only 2.3% edema rate reported in clinical trials

Contraindications: Pregnancy, autoimmune disorders, or active skin infections

Adverse Effects: Temporary swelling, redness, or bruising may occur

Professional Note: Individual results may vary based on anatomical factors and injection technique

Verification: Always verify product authenticity via scratch-off code

• Elravie Premier requires prescription and professional administration

• Must be administered by licensed practitioners only

• Always follow aseptic techniques during administration

• Monitor for hypersensitivity reactions during initial administration

• Manufacturer not liable for complications arising from off-label use or improper storage